DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carboplatin (Carboplatin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Carboplatin and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (2788)
Death (558)
Life Threatening Events (220)
Disability (62)

Reports by Reaction Type

Vomiting (245)Nausea (244)Diarrhoea (237)Anaemia (233)Neutropenia (217)Febrile Neutropenia (206)Dyspnoea (202)Dehydration (166)Fatigue (165)Pyrexia (141)Thrombocytopenia (125)Neutrophil Count Decreased (125)

Below are a few examples of reports where side effects / adverse reactions may be related to Carboplatin. For a complete list or a specific selection of reports, please use the links above.

Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bacteraemia, Hypovolaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 5 df, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-07
    End date: 2012-06-26

Gemcitabine Hydrochloride
    Dosage: 1000 mg/m2, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-07
    End date: 2012-07-02

Other drugs received by patient: Prednisone TAB; Clonidine; Guaifenesin; Albuterol Sulfate; Calcium; Methimazole; Potassium Chloride; Aspirin; Leflunomide



Possible Carboplatin side effects in

Reported by a physician from Netherlands on 2012-08-27

Patient:

Reactions: Disease Progression

Drug(s) suspected as cause:
Avastin
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Indication: non-Small Cell Lung Cancer

Pemetrexed
    Indication: non-Small Cell Lung Cancer



Possible Carboplatin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection

Drug(s) suspected as cause:
Carboplatin
    Dosage: 6 courses in high risk
    Indication: Retinoblastoma

Cyclophosphamide
    Indication: Retinoblastoma

Doxorubicin Hydrochloride
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Etoposide
    Indication: Retinoblastoma

Vincristine
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Other drugs received by patient: Neupogen



Possible Carboplatin side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-27

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cisplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dexamethasone Sodium Phosphate
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Ifosfamide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Rituximab
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Vinblastine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01



Possible Carboplatin side effects in female

Reported by a physician from Germany on 2012-08-27

Patient: female, weighing 72.0 kg (158.4 pounds)

Reactions: Stomatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Start date: 2012-05-16

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-03-15
    End date: 2012-05-02

Doxorubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2012-03-15
    End date: 2012-05-02

Doxorubicin Hydrochloride
    Dosage: 4.7143 milligram daily;
    Start date: 2012-05-16

Lapatinib
    Dosage: 750 milligram daily;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-15

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-03-15
    End date: 2012-05-02

Paclitaxel
    Dosage: 11.4286 mg/m2 daily;
    Start date: 2012-05-16

Trastuzumab
    Indication: Breast Cancer
    Start date: 2012-03-15
    End date: 2012-04-25

Other drugs received by patient: Granocyte; Ciprofloxacin HCL



Possible Carboplatin side effects in 68 year old male

Reported by a physician from United States on 2012-08-27

Patient: 68 year old male, weighing 74.5 kg (163.9 pounds)

Reactions: Lobar Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arixtra
    Indication: Venous Thrombosis
    Start date: 2012-07-18

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-27

Taxol
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-27



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male, weighing 99.9 kg (219.7 pounds)

Reactions: Failure To Thrive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Salivary Gland Cancer

OGX-011
    Start date: 2012-08-08
    End date: 2012-08-08

OGX-011
    Start date: 2012-08-10
    End date: 2012-08-10

OGX-011
    Indication: Salivary Gland Cancer
    Start date: 2012-08-06
    End date: 2012-08-06

Paclitaxel
    Indication: Salivary Gland Cancer

Other drugs received by patient: Oxycodone HCL; Duragesic-12; Atenolol; Tamsulosin HCL; Gabapentin; Finasteride



Possible Carboplatin side effects in male

Reported by a physician from United Kingdom on 2012-08-27

Patient: male, weighing 77.5 kg (170.5 pounds)

Reactions: Supraventricular Tachycardia

Drug(s) suspected as cause:
Carboplatin
    Dosage: 300 mg, 30 min iv infusion, on day 1 of each 21 day cycle
    Indication: Transitional Cell Carcinoma
    Start date: 2012-06-22
    End date: 2012-07-11

Gemcitabine Hydrochloride
    Dosage: 1900 mg, 30 min iv infusion, on day 1 and 8 of each 21 day cycle
    Indication: Transitional Cell Carcinoma
    Start date: 2012-06-22
    End date: 2012-07-19

Zd6474
    Administration route: Oral
    Indication: Transitional Cell Carcinoma
    Start date: 2012-06-22
    End date: 2012-08-01

Other drugs received by patient: Lactulose; Tinzaparin; Acetaminophen and Codeine Phosphate; Acetaminophen and Codeine Phosphate



Possible Carboplatin side effects in male

Reported by a physician from France on 2012-08-27

Patient: male

Reactions: Malaise, Cyanosis, Formication

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 415mg cyclic
    Indication: Lung Neoplasm Malignant
    Start date: 2012-06-20
    End date: 2012-06-20

Methylprednisolone
    Dosage: 40mg single dose
    Indication: Premedication
    Start date: 2012-06-20
    End date: 2012-06-20

Plitican
    Dosage: 150mg single dose
    Indication: Premedication
    Start date: 2012-06-20
    End date: 2012-06-20

Zofran
    Dosage: 8mg single dose
    Indication: Premedication
    Start date: 2012-06-20
    End date: 2012-06-20

Other drugs received by patient: Vinorelbine



Possible Carboplatin side effects in 72 year old female

Reported by a physician from United States on 2012-08-27

Patient: 72 year old female, weighing 71.6 kg (157.5 pounds)

Reactions: Ventricular Arrhythmia

Drug(s) suspected as cause:
Avastin
    Dosage: 15 mg/kg iv over 30-90 minutes on day 1 on 2 cycle onwards
    Indication: Ovarian Epithelial Cancer

Carboplatin
    Dosage: auc 6 (cycle 1-6),6th cycle completed on 16/feb/2012
    Indication: Ovarian Epithelial Cancer
    Start date: 2011-11-23

Ipratropium Bromide
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 175 mg/m2 over 3 hrs on day 1(cycle 1-6), 6th cycle completed on 16/feb/2012
    Indication: Ovarian Epithelial Cancer
    Start date: 2011-11-23



Possible Carboplatin side effects in male

Reported by a physician from France on 2012-08-24

Patient: male

Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: 200 df, unknown/d
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-08-03

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Start date: 2012-08-17

Pemetrexed Disodium
    Dosage: 200 df, unknown/d
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-08-03



Possible Carboplatin side effects in female

Reported by a physician from Ireland on 2012-08-24

Patient: female, weighing 75.5 kg (166.1 pounds)

Reactions: Vomiting, Diarrhoea, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 790mg cyclic
    Indication: Breast Cancer
    Start date: 2012-08-09

Docetaxel
    Dosage: 75mgm2 cyclic
    Indication: Breast Cancer
    Start date: 2012-08-09

Lapatinib
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-08-09

Trastuzumab
    Dosage: 8mgk cyclic
    Indication: Breast Cancer
    Start date: 2012-08-09



Possible Carboplatin side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Dexamethasone



Possible Carboplatin side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: 65 year old male, weighing 83.0 kg (182.6 pounds)

Reactions: White Blood Cell Count Decreased, Platelet Count Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 135mg/m2/auc 4
    Indication: Ovarian Cancer
    Start date: 2012-08-13
    End date: 2012-08-13

Paclitaxel
    Indication: Ovarian Cancer
    Start date: 2012-08-13
    End date: 2012-08-17

Ridaforolimus
    Dosage: 10mg po day 1-5
    Administration route: Oral



Possible Carboplatin side effects in 58 year old male

Reported by a consumer/non-health professional from Argentina on 2012-08-24

Patient: 58 year old male

Reactions: Hepatotoxicity, Neoplasm Malignant, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Start date: 2012-01-01

Yervoy
    Dosage: no of inf:2 infusion on 9feb12
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-02-09



Possible Carboplatin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: , weighing 1.9 kg (4.1 pounds)

Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Carboplatin
    Indication: Ovarian Cancer Stage I

Paclitaxel
    Indication: Ovarian Cancer Stage I



Possible Carboplatin side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-08-24

Patient: 67 year old female

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded: Ipilimumab
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-22

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-10

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-10

Placebo
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-22

Other drugs received by patient: Miralax; Multi-Vitamin; Coumadin; Diphenhydramine Hydrochloride; Dexamethasone; Advair Diskus 100 / 50; Prednisone TAB; Spiriva; Magnesium Oxide; Potassium Chloride; Tramadol HCL; Calcium Carbonate; Coumadin; Omeprazole; Pristiq; Proair HFA



Possible Carboplatin side effects in 74 year old male

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: 74 year old male, weighing 102.0 kg (224.4 pounds)

Reactions: Chronic Obstructive Pulmonary Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: last dose: 02aug12
    Indication: Bronchioloalveolar Carcinoma
    Start date: 2012-05-30

Carboplatin
    Dosage: last dose: 02aug12
    Indication: Bronchioloalveolar Carcinoma
    Start date: 2012-05-30

Paclitaxel
    Dosage: last dose: 02aug12
    Indication: Bronchioloalveolar Carcinoma
    Start date: 2012-05-30



Possible Carboplatin side effects in female

Reported by a pharmacist from United States on 2012-08-24

Patient: female, weighing 139.7 kg (307.3 pounds)

Reactions: Glossodynia, Unresponsive To Stimuli, Hypoxia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient: Lorazepam; Warfarin Sodium; Nifedipine; Citalopram Hydrobromide; Fiornal; Joint Food; Tylox; Losartan Potassium; Omeprazole; Paclitaxel; Calcium D3; Dexamethasone



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Adriamycin PFS
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etoposide
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium



Possible Carboplatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24

Patient: female

Reactions: Urticaria, Bronchospasm, Laryngeal Oedema, Muscle Rigidity

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23

Patient: 59 year old female

Reactions: Encephalopathy

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Carboplatin
    Start date: 2012-07-20
    End date: 2012-07-20

Etoposide
    Start date: 2012-07-19
    End date: 2012-07-21

Ifosfamide
    Start date: 2012-07-20
    End date: 2012-07-21

Mabthera
    Start date: 2012-07-19
    End date: 2012-07-19

Mesna
    Start date: 2012-07-20
    End date: 2012-07-21

Other drugs received by patient: Solu-Medrol; Acetaminophen; Polaramine



Possible Carboplatin side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-08-23

Patient: female, weighing 81.1 kg (178.5 pounds)

Reactions: Anaemia, Lymphocyte Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 625 mg

Taxol
    Dosage: 320 mg



Possible Carboplatin side effects in 68 year old male

Reported by a physician from United States on 2012-08-23

Patient: 68 year old male, weighing 74.5 kg (163.9 pounds)

Reactions: Lobar Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arixtra
    Indication: Venous Thrombosis

Carboplatin
    Indication: non-Small Cell Lung Cancer

Taxol
    Indication: non-Small Cell Lung Cancer



Possible Carboplatin side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-08-23

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Weight Decreased, Escherichia Test Positive, Malaise, Vomiting, Nausea, Dysuria, Clostridium Difficile Colitis, Culture Urine Positive, Thrombocytopenia, Enterobacter Test Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 376 mg

Taxol
    Dosage: 299 mg



Possible Carboplatin side effects in female

Reported by a physician from Germany on 2012-08-23

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-06-15

Lapatinib
    Dosage: 750mg per day
    Indication: Breast Cancer
    Start date: 2012-06-15

Liposome Encapsulated Doxorubicin Citrate Complex
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-15

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-15

Trastuzumab
    Dosage: 6mgk every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-06-15

Other drugs received by patient: Loperamide; Neupogen



Possible Carboplatin side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient: 68 year old female, weighing 112.0 kg (246.5 pounds)

Reactions: Flushing, Nausea, Feeling Hot, Chest Pain

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient: Avastin



Possible Carboplatin side effects in female

Reported by a physician from Germany on 2012-08-23

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 5 auc
    Indication: Breast Cancer
    Start date: 2012-04-25

Docetaxel
    Indication: Breast Cancer
    Start date: 2012-04-25

Herceptin
    Indication: Breast Cancer
    Start date: 2012-04-25

Herceptin

Placebo
    Indication: Breast Cancer
    Start date: 2012-04-25

Other drugs received by patient: Metoprolol Tartrate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014